These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

451 related articles for article (PubMed ID: 30906962)

  • 1. Some aspects on the pathophysiology of migraine and a review of device therapies for migraine and cluster headache.
    Rapoport AM; Edvinsson L
    Neurol Sci; 2019 May; 40(Suppl 1):75-80. PubMed ID: 30906962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of anti-CGRP antibodies in the pathophysiology of primary headaches.
    Barbanti P; Aurilia C; Fofi L; Egeo G; Ferroni P
    Neurol Sci; 2017 May; 38(Suppl 1):31-35. PubMed ID: 28527063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CGRP and headache: a brief review.
    Tepper SJ
    Neurol Sci; 2019 May; 40(Suppl 1):99-105. PubMed ID: 30835001
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calcitonin Gene-Related Peptide-Targeted Therapies for Migraine and Cluster Headache: A Review.
    Schuster NM; Rapoport AM
    Clin Neuropharmacol; 2017; 40(4):169-174. PubMed ID: 28644160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting CGRP for the Prevention of Migraine and Cluster Headache: A Narrative Review.
    Yuan H; Spare NM; Silberstein SD
    Headache; 2019 Jul; 59 Suppl 2():20-32. PubMed ID: 31291020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CGRP, a target for preventive therapy in migraine and cluster headache: Systematic review of clinical data.
    Khan S; Olesen A; Ashina M
    Cephalalgia; 2019 Mar; 39(3):374-389. PubMed ID: 29110503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Galcanezumab effectiveness on comorbid cluster headache and chronic migraine: a prospective case series.
    Iannone LF; Fattori D; Geppetti P; De Cesaris F
    Neurol Sci; 2022 Jan; 43(1):697-703. PubMed ID: 34586542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CGRP pathway monoclonal antibodies for cluster headache.
    Chan C; Goadsby PJ
    Expert Opin Biol Ther; 2020 Aug; 20(8):947-953. PubMed ID: 32241175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-CGRP in cluster headache therapy.
    Giani L; Proietti Cecchini A; Leone M
    Neurol Sci; 2019 May; 40(Suppl 1):129-135. PubMed ID: 30820761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aspects on the pathophysiology of migraine and cluster headache.
    Edvinsson L
    Pharmacol Toxicol; 2001 Aug; 89(2):65-73. PubMed ID: 11555322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Galcanezumab: a humanized monoclonal antibody for the prevention of migraine and cluster headache.
    Ossipov MH; Raffa RB; Pergolizzi JV
    Drugs Today (Barc); 2020 Jan; 56(1):5-19. PubMed ID: 32055802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Migraine and cluster headache - the common link.
    Vollesen AL; Benemei S; Cortese F; Labastida-Ramírez A; Marchese F; Pellesi L; Romoli M; Ashina M; Lampl C;
    J Headache Pain; 2018 Sep; 19(1):89. PubMed ID: 30242519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of nitric oxide (NO) in migraine, tension-type headache and cluster headache.
    Olesen J
    Pharmacol Ther; 2008 Nov; 120(2):157-71. PubMed ID: 18789357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New treatments for headache.
    Vollbracht S; Rapoport AM
    Neurol Sci; 2014 May; 35 Suppl 1():89-97. PubMed ID: 24867844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Verisimilitude (or "truthlikeness") as an alternative to pro and cons: migraine and cluster headache mechanisms.
    Tfelt-Hansen PC
    J Headache Pain; 2010 Oct; 11(5):379-89. PubMed ID: 20607582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calcitonin gene-related peptide antagonism and cluster headache: an emerging new treatment.
    Ashina H; Newman L; Ashina S
    Neurol Sci; 2017 Dec; 38(12):2089-2093. PubMed ID: 28856479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advances in the field of headache 2003/2004.
    Diener HC
    Curr Opin Neurol; 2004 Jun; 17(3):271-3. PubMed ID: 15167060
    [No Abstract]   [Full Text] [Related]  

  • 18. Sumatriptan. A reappraisal of its pharmacology and therapeutic efficacy in the acute treatment of migraine and cluster headache.
    Plosker GL; McTavish D
    Drugs; 1994 Apr; 47(4):622-51. PubMed ID: 7516861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CGRP-receptor antagonism in migraine treatment.
    Edvinsson L; Petersen KA
    CNS Neurol Disord Drug Targets; 2007 Aug; 6(4):240-6. PubMed ID: 17691979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of acute and preventive therapies for episodic and chronic cluster headache: A scoping review of the literature.
    Medrea I; Christie S; Tepper SJ; Thavorn K; Hutton B
    Headache; 2022 Mar; 62(3):329-362. PubMed ID: 35315067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.